Abstract
Phthalocyanines exhibit superior photoproperties that make them a surely attractive class of photosensitisers for photodynamic therapy of cancer. Several derivatives are at various phases of clinical trials, and efforts have been put continuously to improve their photodynamic efficacy. To this end, various strategies have been applied to develop advanced phthalocyanines with optimised photoproperties, dual therapeutic actions, tumour-targeting properties and/or specific activation at tumour sites. The advantageous properties and potential of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer are highlighted in this tutorial review.
| Original language | English |
|---|---|
| Pages (from-to) | 1041-1056 |
| Journal | Chemical Society Reviews |
| Volume | 49 |
| Issue number | 4 |
| Online published | 17 Dec 2019 |
| DOIs | |
| Publication status | Published - 21 Feb 2020 |
Bibliographical note
Information for this record is supplemented by the author(s) concerned.UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Keywords
- Phthalocyanine
- Photodynamic therapy
ESI Highly Cited Papers
- Highly Cited Paper 2020
- Highly Cited Paper 2021
- Highly Cited Paper 2026
- Highly Cited Paper 2024
- Highly Cited Paper 2025
- Highly Cited Paper 2022
- Highly Cited Paper 2023
ESI Hot Papers
- Hot Paper 2022
- Hot Paper 2021
Fingerprint
Dive into the research topics of 'The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver